Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 20:11:1447315.
doi: 10.3389/fmolb.2024.1447315. eCollection 2024.

PBMC-engrafted humanized mice models for evaluating immune-related and anticancer drug delivery systems

Affiliations
Review

PBMC-engrafted humanized mice models for evaluating immune-related and anticancer drug delivery systems

Yoshie Kametani et al. Front Mol Biosci. .

Abstract

Immune-related drug delivery systems (DDSs) in humanized mouse models are at the forefront of cancer research and serve as bridges between preclinical studies and clinical applications. These systems offer unique platforms for exploring new therapies and understanding their interactions with human cells and the immune system. Here, we focus on a DDS and a peripheral blood mononuclear cell (PBMC)-engrafted humanized mouse model that we recently developed, and consider some of the key components, challenges, and applications to advance these systems towards better cancer treatment on the basis of a better understanding of the immune response. Our DDS is unique and has a dual function, an anticancer effect and a capacity to fine-tune the immune reaction. The PBL-NOG-hIL-4-Tg mouse system is superior to other available humanized mouse systems for the development of such multifunctional DDSs because it supports the rapid reconstruction of an individual donor's immunity and avoids the onset of graft-versus-host disease.

Keywords: anticancer drug; drug delivery system; hematopoietic stem cells; humanized mouse; immune system; peripheral blood mononuclear cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Reconstruction of human immune profiles in immune humanized mouse. (A) Human hematopoietic stem cell (HSC) transplantation. In mouse (Mo) bone marrow (BM), spleen and lymph node (LN) tissue, human lymphoid and myeloid cells develop into various blood cells, but erythroid cells are not engrafted. (B) Healthy donor peripheral blood mononuclear cell (PBMC) transplantation. Only T cells are activated through xenogeneic reaction. (C) Transplantation of healthy donor PBMC in the presence of human IL-4 (indicated by small orange circles). T cells are not activated through xenogeneic reaction and other cells survive. (D) Transplantation of breast cancer patient PBMC in the presence of human IL-4 (indicated by small orange circles). The immune suppressive characteristics are reflected in the mouse.

References

    1. Alijaj N., Moutel S., Gouveia Z. L., Gray M., Roveri M., Dzhumashev D., et al. (2020). Novel FGFR4-targeting single-domain antibodies for multiple targeted therapies against rhabdomyosarcoma. Cancers (Basel) 12, 3313. 10.3390/cancers12113313 - DOI - PMC - PubMed
    1. Amissah O. B., Chen W., de Dieu Habimana J., Sun Y., Lin L., Liu Y., et al. (2024). NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route. Cancer Cell. Int. 24, 64. 10.1186/s12935-024-03249-w - DOI - PMC - PubMed
    1. Attarwala H. (2010). TGN1412: from discovery to disaster. J. Young Pharm. 2, 332–336. 10.4103/0975-1483.66810 - DOI - PMC - PubMed
    1. Baliu-Piqué M., Tesselaar K., Borghans J. A. M. (2022). Are homeostatic mechanisms aiding the reconstitution of the T-cell pool during lymphopenia in humans? Front. Immunol. 13, 1059481. 10.3389/fimmu.2022.1059481 - DOI - PMC - PubMed
    1. Bennett G., Brown A., Mudd G., Huxley P., Van Rietschoten K., Pavan S., et al. (2020). MMAE delivery using the bicycle toxin conjugate BT5528. Mol. Cancer. Ther. 19, 1385–1394. 10.1158/1535-7163.MCT-19-1092 - DOI - PubMed

LinkOut - more resources